Barclays’s Biomea Fusion BMEA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.34K Sell
1,593
-50,013
-97% -$74.6K ﹤0.01% 4857
2026
Q1
$79K Sell
51,606
-7,407
-13% -$9.73K ﹤0.01% 4132
2025
Q4
$73.2K Buy
59,013
+55,790
+1,731% +$78.1K ﹤0.01% 4663
2025
Q3
$6.51K Sell
3,223
-670
-17% -$1.23K ﹤0.01% 5059
2025
Q2
$7.01K Sell
3,893
-29,795
-88% -$57.4K ﹤0.01% 4941
2025
Q1
$71.8K Sell
33,688
-13,216
-28% -$45K ﹤0.01% 4508
2024
Q4
$182K Buy
46,904
+7,284
+18% +$58K ﹤0.01% 4358
2024
Q3
$400K Buy
39,620
+24,162
+156% +$157K ﹤0.01% 3910
2024
Q2
$69.6K Sell
15,458
-31,359
-67% -$319K ﹤0.01% 4073
2024
Q1
$700K Sell
46,817
-25,451
-35% -$419K ﹤0.01% 3373
2023
Q4
$1.05M Sell
72,268
-44,353
-38% -$539K ﹤0.01% 3408
2023
Q3
$1.6M Buy
116,621
+49,485
+74% +$892K ﹤0.01% 2020
2023
Q2
$1.47M Buy
67,136
+57,907
+627% +$1.81M ﹤0.01% 2075
2023
Q1
$286K Sell
9,229
-982
-10% -$12.2K ﹤0.01% 3602
2022
Q4
$86.1K Buy
10,211
+8,964
+719% +$76.5K ﹤0.01% 4317
2022
Q3
$12K Buy
1,247
+284
+29% +$3.26K ﹤0.01% 4228
2022
Q2
$12K Sell
963
-3,522
-79% -$20.6K ﹤0.01% 4565
2022
Q1
$20K Buy
+4,485
New +$29.1K ﹤0.01% 4440

Other funds holding BMEA

Barclays's BMEA Position: Q2 2026 in Review

Barclays reduced its Biomea Fusion (BMEA) stake by 97% in Q2 2026, selling an estimated $74.6K and leaving 1,593 shares worth $2.34K. The position accounts for ﹤0.01% of the portfolio, ranked #4857.

Barclays first reported a position in BMEA in Q1 2022 and has held it in 18 quarters since. The position peaked at $1.6M in Q3 2023. 61 funds tracked by Wall St. Rank hold BMEA as of Q2 2026.

  • Barclays held 1,593 shares of Biomea Fusion worth $2.34K as of Q2 2026.
  • Barclays sold 50,013 Biomea Fusion shares in Q2 2026, an estimated $74.6K.
  • Biomea Fusion made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #4857 holding.
  • Barclays first reported a position in Biomea Fusion in Q1 2022 and has held it in 18 quarters since.
  • Barclays's Biomea Fusion position peaked at $1.6M in Q3 2023.
  • 61 funds tracked by Wall St. Rank held Biomea Fusion as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.